In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment
In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment https://www.metabolism-cancer.com/wp-content/uploads/2021/05/FERNANDEZ-_Thais-att_page-0001-scaled.jpg 2425 2560 Metabolism & Cancer //www.metabolism-cancer.com/wp-content/uploads/2024/10/METABO_2025_696x696px.png 